The content on this site is intended for healthcare professionals only
Effects of panitumumab against oesophageal-gastro cancer and carcinomas
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies
President's overview of ASCO 2012
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies
Continuing bevacizumab with second-line chemotherapy for colorectal cancer
Primary and secondary resistance in colorectal cancer
Analysis of thirty years of clinical trial data
Infectious diseases as a cause of cancer
Aspirin for the elderly to reduce cancer risk
Update on aspirin and cancer prevention
Evidence for use of aspirin to prevent cancer
Aspirin and cancer - the patient voice
